LightDeck Diagnostics

LightDeck Diagnostics, headquartered in Boulder, Colorado, is a privately held biotechnology company specializing in rapid diagnostic testing solutions. Founded in 2016, LightDeck Diagnostics employs 34 individuals and generates annual revenue of $20 million. LightDeck Diagnostics offers a range of diagnostic tests, primarily focusing on in vitro diagnostics. Their flagship product is the LightDeck® platform, a portable fluorescence analyzer paired with disposable, multiplex test cartridges. This platform allows for lab-quality diagnostic results in as little as 5 minutes, delivering actionable data for various applications, including COVID-19 testing, veterinary diagnostics, and environmental testing. The LightDeck® platform distinguishes itself through its unique combination of speed, accuracy, and portability. Its proprietary laser waveguide technology, coupled with innovative materials and manufacturing techniques, ensures highly sensitive tests capable of producing quantitative results. Furthermore, the platform's multiplex capability enables simultaneous testing for multiple related conditions, enhancing diagnostic precision and incorporating internal quality control measures to ensure reliable and trustworthy outcomes. To learn more about LightDeck Diagnostics and its innovative diagnostic solutions, visit www.LightDeckDx.com.